The Bcl-2 status did not correlate with DSS (p = 0.21), tumor localization (p = 0.531), tumor size (p = 0.136), stage (p= 0.748), lymph node metastasis (p = 0.111) or response to neoadjuvant chemotherapy (p = 0.544). Here, BCL2 is linked to neoplasm.